as 07-26-2024 4:00pm EST
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | GUILFORD |
Market Cap: | 75.6M | IPO Year: | N/A |
Target Price: | $2.12 | AVG Volume (30 days): | 231.1K |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.59 | EPS Growth: | N/A |
52 Week Low/High: | $0.76 - $3.15 | Next Earning Date: | 08-08-2024 |
Revenue: | $11,692,000 | Revenue Growth: | 47.25% |
Revenue Growth (this year): | 20.78% | Revenue Growth (next year): | 28.07% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
TEISSEYRE THOMAS | HYPR | Chief Operating Officer | May 16 '24 | Sell | $0.88 | 2,753 | $2,422.64 | 93,773 | SEC Form 4 |
TEISSEYRE THOMAS | HYPR | Chief Operating Officer | Feb 16 '24 | Sell | $1.11 | 3,230 | $3,585.30 | 96,526 | SEC Form 4 |
TEISSEYRE THOMAS | HYPR | Chief Operating Officer | Nov 16 '23 | Sell | $1.26 | 2,655 | $3,345.30 | 99,756 | SEC Form 4 |
HYPR Breaking Stock News: Dive into HYPR Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
Business Wire
11 days ago
Business Wire
15 days ago
Business Wire
16 days ago
Business Wire
a month ago
Business Wire
2 months ago
Business Wire
2 months ago
Business Wire
2 months ago
The information presented on this page, "HYPR Hyperfine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.